News
Parents urged to get children checked for dry eye disease
Dry eye disease (DED) has become a feature of teenage and young adult life, rather than a condition which traditionally troubled only the middle-aged. The problem is largely unrecognised, says a leading figure in children’s vision and eyecare, Prof James...
OSA dry eye disease group forms for technology providers
Dry eye disease diagnostic and therapy technology providers have formed a specialist OSA and Optic UK group to collaborate and provide optimum support for the profession. Led by Ross Bailey, SCOPE Eyecare Professional Relations and Partnerships Manager, and Nicola Bennett,...
Conference Report: EUDEC 2025
This year, the European Dry Eye Society held its annual Congress in the historic city of Krakow, Poland. The Congress location was Fabryczna 13, a modern complex located in the restored buildings of an old vodka factory built in the...
From dry eyes to glaucoma: How the menopause impacts your eyes and what to do about it, according to an optician
Menopause, much like entering puberty, comes with hormonal disruptions that change a woman's body and behaviour. Some of the first visible side effects are hot flushes, weight gain, and acne, accompanied by behavioural symptoms like mood swings, insomnia, and brain...
New study maps priorities for UK eyecare research
Glaucoma, age-related macular degeneration, childhood vision loss, and short-sightedness are highlighted as target study areas.
Preview: ISD-DE 2024
A preview of the 14th Congress of the International Society of Dacrylogy and Dry Eye, in London 29–31 May 2024.
Andy Hill (NuVision Biotherapies) discusses recent AOP update to clinical guidelines
There are currently 600,000 people on the NHS waiting list for ophthalmology treatment, and over 5 million people in the UK currently live with dry eye disease. Here Andy Hill, CEO at NuVision Biotherapies Ltd, discusses a recent update to clinical guidelines and what this means for optometrists, patients, and taxpayers.
